Asia
The Aspirin market in Asia demonstrated a notable upward trajectory during Q3’24. The initial market conditions showed moderate pricing levels, but prices gradually increased due to robust demand and tightening supply conditions. The downstream pharmaceutical sector exhibited strong buying sentiment, particularly in China, leading suppliers to maintain firm pricing positions.
Transportation costs remained a significant factor, with elevated freight rates contributing to increased operational costs. Market participants actively engaged in inventory building activities, especially towards the latter part of the quarter, as geopolitical tensions created supply uncertainty. The consistent demand from both domestic and export markets supported the price surge for aspirin throughout the period.
Europe
European aspirin prices followed an inclining trajectory throughout Q3 2024, primarily influenced by strong market fundamentals and supply chain disruptions. The market witnessed increased buying activity, particularly from pharmaceutical manufacturers and healthcare sectors. Despite high logistics costs pressuring margins, sellers successfully implemented price hikes amid favourable market dynamics. Towards the end of quarter, prices stabilized at elevated levels as seasonal demand patterns emerged and supply constraints persisted.
North America
The US domestic market experienced steady price appreciation during Q3’24. The initial phase saw moderate increases driven by rising production costs and stable demand from end-user industries. Mid-quarter prices accelerated upward as supply chain bottlenecks intensified and raw material costs surged. Market sentiment remained bullish throughout the period, supported by strong consumer demand and strategic inventory management by key market participants.